Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Desmopressin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    40 result(s) found for: Desmopressin. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2011-004540-22 Sponsor Protocol Number: AGO/2011/009 Start Date*: 2011-10-25
    Sponsor Name:Ghent University Hospital
    Full Title: Desmopressin melt therapy in nocturnal polyuria patients: pharmacokinetic/dynamic study
    Medical condition: Nocturia and noctural polyuria
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038359 - Renal and urinary disorders 10064016 Nocturnal polyuria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005200-13 Sponsor Protocol Number: SafePed002 Start Date*: 2015-07-09
    Sponsor Name:Ghent University
    Full Title: study of the pharmacokinetics and pharmacodynamics of desmopressin oral lyophilisate - route of administration in the pediatric patient population - SAFEPEDRUG
    Medical condition: therapeutic population: monosympthomatic enuresis nocturna diagnostic population: children with a history of a urinary tract infection or suspicion of renal damage who need a renal concentration...
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2018-001904-12 Sponsor Protocol Number: 18040 Start Date*: Information not available in EudraCT
    Sponsor Name:University of Nottingham
    Full Title: Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH)
    Medical condition: Intracerebral haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029205 - Nervous system disorders 10019016 Haemorrhagic stroke PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2011-000527-33 Sponsor Protocol Number: AGO/2011/001 Start Date*: 2011-03-21
    Sponsor Name:Ghent University Hospital
    Full Title: Characteristics of adult patients with nocturia and nocturnal polyuria and analysis of pharmacokinetic and –dynamic characteristics of desmopressin Melt in this population
    Medical condition: Nocturia and nocturnal polyuria
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-004560-29 Sponsor Protocol Number: AGO/2011/010 Start Date*: 2011-10-25
    Sponsor Name:Ghent University Hospital
    Full Title: Desmopressin melt therapy in nocturnal polyuria patients: pharmacodynamic study
    Medical condition: Noctural polyuria
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038359 - Renal and urinary disorders 10064016 Nocturnal polyuria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-001735-37 Sponsor Protocol Number: FL-CR001 Start Date*: 2006-02-16
    Sponsor Name:FERRING ARZNEIMITTEL Ges.m.b.h. CEE AUSTRIA
    Full Title: AN OPEN LABEL STUDY OF ORAL DESMOPRESSIN IN CHILDREN AGED 5 TO 15 YEARS WITH PRIMARY NOCTURAL ENURESIS
    Medical condition: Primary noctural enuresis
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-004388-34 Sponsor Protocol Number: 000088 Start Date*: 2013-03-06
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: A Double-blind, Randomised, Parallel-group Trial Investigating Sleep Behaviour and Daytime Performance in Nocturia Patients Treated with Desmopressin Orally Disintegrating Tablets as compared to Pl...
    Medical condition: Nocturia
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-001126-33 Sponsor Protocol Number: 15/87 Start Date*: 2016-11-29
    Sponsor Name:NHS Blood and Transplant
    Full Title: A placebo-controlled double blind, randomised feasibility trial of Desmopressin (DDAVP) in critical illness prior to procedures.
    Medical condition: Thrombocytopenic patients (platelet count less than or equal to 100x109/L) in Intensive Care and due to undergo an interventional procedure.
    Disease: Version SOC Term Classification Code Term Level
    19.0 10042613 - Surgical and medical procedures 10036898 Prophylaxis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-000666-35 Sponsor Protocol Number: AGO/2011/002 Start Date*: 2011-03-21
    Sponsor Name:Ghent University Hospital
    Full Title: Analysis of the effect and side effects of desmopressin melt in patients with nocturnal polyuria.
    Medical condition: Nocturia and noctural polyuria
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2021-006647-99 Sponsor Protocol Number: 2021/ABM/01/00010 Start Date*: 2022-03-02
    Sponsor Name:Medical University of Bialystok
    Full Title: Safety Outcomes Post kidney Biopsy – randomized Clinical Evaluation of Efficacy of Desmopressin
    Medical condition: Rare and ultra-rare glomerulonephritis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10038359 - Renal and urinary disorders 10018364 Glomerulonephritis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2017-002169-23 Sponsor Protocol Number: DRYCHILD Start Date*: 2017-09-06
    Sponsor Name:Søren Rittig
    Full Title: The effect of clinical characterization of children with monosymptomatic nocturnal enuresis on the efficacy of desmopressin and alarm therapy.
    Medical condition: Enuresis nocturna
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004873 10014930 Enuresis (non-organic) LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Completed) BE (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2016-001875-57 Sponsor Protocol Number: 106524 Start Date*: 2017-03-13
    Sponsor Name:Erasmus University Medical Center Rotterdam
    Full Title: Desmopressin and FVIII concentrate combination treatment in non-severe hemophilia A patients undergoing minor interventions
    Medical condition: Hemophilia A
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004850 10060613 Hemophilia A (Factor VIII) LLT
    20.0 100000004850 10053753 Hemophilia A without inhibitors LLT
    20.0 100000004850 10060612 Hemophilia A LLT
    Population Age: Adolescents, Under 18, Elderly Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-004496-38 Sponsor Protocol Number: CPH-DDAVPISTH-1 Start Date*: 2006-06-22
    Sponsor Name:Rigshospitalet, Copenhagen
    Full Title: Desmopressin in the management of von Willebrand disease; Biological versus clinical efficacy.
    Medical condition: von Willebrand disease (VWD) is an inherited bleeding disorder, characterised mainly by mucosal bleedings, which may be life-threatening, and joint bleeds in severe VWD cases. VWD is caused by a la...
    Disease:
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-003966-25 Sponsor Protocol Number: DEPOPA Start Date*: 2008-12-23
    Sponsor Name:Universität Mainz, Klinik und Poliklinik für Neurologie
    Full Title: Double-blind, placebo controlled, randomised, monocenter cross-over studie to evaluate the effect of Desmopressin on the nocturnal polyuria in patients with idiopathic Parkinson Syndrome compared t...
    Medical condition: Effect of Desmopressin on the nocturnal polyuria in patients with idiopathic Parkinson Syndrome
    Disease: Version SOC Term Classification Code Term Level
    9.1 10064016 Nocturnal polyuria LLT
    9.1 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-002636-15 Sponsor Protocol Number: U-08-001 Start Date*: 2009-04-29
    Sponsor Name:Uppsala University Children´s Hospital
    Full Title: Study on the treatment of therapy-resistant enuresis with desmopressin and reboxetine; a randomised, placebo-controlled, double-blinded, cross-over study
    Medical condition: Nocturnal enuresis (bedwetting)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10014928 Enuresis LLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017265-33 Sponsor Protocol Number: AGO/2009/011 Start Date*: 2009-12-23
    Sponsor Name:University Hospital Ghent
    Full Title: Invloed van voeding op farmacokinetiek en -dynamiek van desmopressine tablet in vergelijking met desmopressine MELT-vorm
    Medical condition: Kinderen met Monosymptomatische Enuresis Nocturna en nachtelijke polyurie
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-000593-32 Sponsor Protocol Number: FE992026 CS022 Start Date*: 2004-12-16
    Sponsor Name:Ferring Arzneimittel GmbH
    Full Title: A 6-week open label cross-over study with 2 different daily doses of Minirin oral lyophilisate (120 µg and 240 µg) and 2 different daily doses of Minirin tablet (0.2 mg and 2 x 0.2 mg) in children ...
    Medical condition: Primary Nocturnal Enuresis
    Disease: Version SOC Term Classification Code Term Level
    6.1 10029453 low
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed) SE (Completed) FI (Completed) DK (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004371-19 Sponsor Protocol Number: ARC1779-004 Start Date*: 2007-11-20
    Sponsor Name:Archemix Corp.
    Full Title: A Phase 2 Pilot Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 Injection in Patients with von Willebrand Factor-Related Platelet Function Disorders
    Medical condition: von Willebrand Factor- related platelet function disorders : thrombotic thrombocytopenic purpura(TTP) in remission, acute TTP, and von Willebrand Disease Type- 2b (vWD-2b).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037563 Purpura thrombopenic thrombotic LLT
    9.1 10047715 Von Willebrand's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004559-36 Sponsor Protocol Number: 1 Start Date*: 2006-03-23
    Sponsor Name:Abteilung für Herz-Thorax-Gefäß Anästhesie & Intensivmedizin (HTG)
    Full Title: Desmopressin in Acquired von Willebrand Syndrome caused by Aortic Valve Stenosis
    Medical condition: Acquired type 2A von Willebrand syndrome is common in patients with severe aortic valve stenosis (AS). It originates from the mechanical obstruction of blood flow and the consecutive proteolysis of...
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000808-22 Sponsor Protocol Number: 000278 Start Date*: 2017-11-13
    Sponsor Name:Ferring Pharmaceuticals A/S
    Full Title: An Open-label Trial Investigating the Association Between Nocturia and Sleep During 12 Weeks of Treatment with Desmopressin Orally Disintegrating Tablet (ODT) for Nocturia due to Nocturnal Polyuria...
    Medical condition: Nocturia due to Nocturnal Polyuria
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000017861 10064016 Nocturnal polyuria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) NL (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 09:22:27 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA